With seven compassionate-use cases under its belt and commercialization in view, VeinWay—developer of the Traversa, a tool for crossing tough venous occlusions—is at a crucial point in its evolution. That is according to chief executive officer (CEO) and co-founder Jordan Pollack, who recently spoke with Venous News about the company’s short- and longer-term goals. He … Continue reading VeinWay CEO: “This is a pivotal year for us”